Healthcare Professionals
IN.PACT Admiral Drug-Coated Balloon
Paclitaxel Coated Balloon
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Healthcare Professionals
IN.PACT Admiral Drug-Coated Balloon
Paclitaxel Coated Balloon
Maintain long-term vessel patency with the IN.PACT™ Admiral™ drug-coated balloon (DCB), which provides durable, consistent, and safe outcomes across multiple clinical trials, as well as across complex patient and lesion types. With more than 3,500 patients enrolled in 21 clinical studies and 200,000+ patients treated, the IN.PACT Admiral balloon is the market-leading DCB for treatment of femoropopliteal disease with 75% of patients reintervention-free at 5 years.1This matters now more than ever.†
The IN.PACT Admiral is indicated for percutaneous transluminal angioplasty (PTA) in patients with obstructive disease of peripheral arteries, including in-stent restenosis (ISR), and with obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
The IN.PACT Admiral DCB is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces interventions, and preserves future treatment options.
IN.PACT Admiral DCB, with sustained drug release up to 180 days,2 has the:
Only the IN.PACT Admiral DCB releases drug into the tissue through the restenotic window.
IN.PACT Admiral Drug-Coated Balloon Mechanism of Action - (02:41)
See how the DCB works.
More information (see more)
Less information (see less)
DCB therapies have been around since 2001, when Dr. Bruno Scheller and Dr. Ulrich Speck envisioned combining mechanical dilatation from PTA with restenosis inhibition from a drug into a single device.
DCB: Decades of Development - (05:38)
Watch the evolution from concept into a frontline therapy for PAD.
More information (see more)
Less information (see less)
Instructions for use.
Find this technical manual in the product labeling supplied with each device.
Feature | Specifications |
---|---|
Paclitaxel Drug Dose | 3.5 µg/mm2 |
Excipient | Urea |
Balloon Diameters | 4 mm to 12 mm |
Balloon Lengths | 40, 60, 80, 120, 150 mm* |
Balloon Fold Configuration | 4.0 mm: 3 folds; 5.0, 6.0, and 7.0 mm: 6 folds |
Catheter Design | Over the wire (OTW) |
Catheter Lengths | 40 cm, 80 cm and 130 cm |
Guidewire Compatibility | 0.035" |
Nominal Balloon Pressure | 8 atm |
*120 mm and 150 mm lengths are not offered on the 7.0 mm diameter balloon.
Ref. N° Usable Length 40 cm |
Ref. N° Usable Length 80 cm |
Ref. N° Usable Length 130 cm |
Balloon Diameter (mm) |
Balloon Length (mm) |
---|---|---|---|---|
SBI 040 040 04P | SBI 040 040 08P | SBI 040 040 13P | 4 | 40 |
SBI 040 060 04P | SBI 040 060 08P | SBI 040 060 13P | 4 | 60 |
SBI 040 080 04P | SBI 040 080 08P | SBI 040 080 13P | 4 | 80 |
- | SBI 040 120 08P | SBI 040 120 13P | 4 | 120 |
- | SBI 040 150 08P | SBI 040 150 13P | 4 | 150 |
SBI 050 040 04P | SBI 050 040 08P | SBI 050 040 13P | 5 | 40 |
SBI 050 060 04P | SBI 050 060 08P | SBI 050 060 13P | 5 | 60 |
SBI 050 080 04P | SBI 050 080 08P | SBI 050 080 13P | 5 | 80 |
- | SBI 050 120 08P | SBI 050 120 13P | 5 | 120 |
- | SBI 050 150 08P | SBI 050 150 13P | 5 | 150 |
SBI 060 040 04P | SBI 060 040 08P | SBI 060 040 13P | 6 | 40 |
SBI 060 060 04P | SBI 060 060 08P | SBI 060 060 13P | 6 | 60 |
SBI 060 080 04P | SBI 060 080 08P | SBI 060 080 13P | 6 | 80 |
- | SBI 060 120 08P | SBI 060 120 13P | 6 | 120 |
- | SBI 060 150 08P | SBI 060 150 13P | 6 | 150 |
SBI 070 040 04P | SBI 070 040 08P | SBI 070 040 13P | 7 | 40 |
SBI 070 060 04P | SBI 070 060 08P | SBI 070 060 13P | 7 | 60 |
SBI 070 080 04P | SBI 070 080 08P | SBI 070 080 13P | 7 | 80 |
SBI 080 040 04P | SBI 080 040 08P | SBI 080 040 13P | 8 | 40 |
SBI 080 060 04P | SBI 080 060 08P | SBI 080 060 13P | 8 | 60 |
SBI 080 080 04P | SBI 080 080 08P | SBI 080 080 13P | 8 | 80 |
SBI 090 040 04P | SBI 090 040 08P | SBI 090 040 13P | 9 | 40 |
SBI 090 060 04P | SBI 090 060 08P | SBI 090 060 13P | 9 | 60 |
SBI 090 080 04P | SBI 090 080 08P | SBI 090 080 13P | 9 | 80 |
SBI 100 040 04P | SBI 100 040 08P | SBI 100 040 13P | 10 | 40 |
SBI 120 040 04P | SBI 120 040 08P | SBI 120 040 13P | 12 | 40 |
Ref. N° Usable Length 90 cm |
Ref. N° Usable Length 130 cm |
Balloon Diameter (mm) |
Balloon Length (mm) |
---|---|---|---|
PCF 040 040 09P | PCF 040 040 13P | 4 | 40 |
PCF 040 060 09P | PCF 040 060 13P | 4 | 60 |
PCF 040 080 09P | PCF 040 080 13P | 4 | 80 |
PCF 040 120 09P | PCF 040 120 13P | 4 | 120 |
PCF 050 040 09P | PCF 050 040 13P | 5 | 40 |
PCF 050 060 09P | PCF 050 060 13P | 5 | 60 |
PCF 050 080 09P | PCF 050 080 13P | 5 | 80 |
PCF 050 120 09P | PCF 050 120 13P | 5 | 120 |
PCF 060 040 09P | PCF 060 040 13P | 6 | 40 |
PCF 060 060 09P | PCF 060 060 13P | 6 | 60 |
PCF 060 080 09P | PCF 060 080 13P | 6 | 80 |
PCF 060 120 09P | PCF 060 120 13P | 6 | 120 |
PCF 070 040 09P | PCF 070 040 13P | 7 | 40 |
PCF 070 060 09P | PCF 070 060 13P | 7 | 60 |
PCF 070 080 09P | PCF 070 080 13P | 7 | 80 |
PCF 070 120 09P | PCF 070 120 13P | 7 | 120 |
See product catalog for complete, detailed product information.
*™Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
†The potential for fewer visits to a healthcare provider may reduce exposure to COVID-19-related risks.
‡Primary patency not assessed after 3 years.
§Data and additional comparative data on file with Medtronic.